Metabolites of a Tobacco-Specific Carcinogen in Urine From Newborns
Open Access
- 3 March 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 91 (5) , 459-465
- https://doi.org/10.1093/jnci/91.5.459
Abstract
BACKGROUND: Cigarette smoking during pregnancy can result in fetal exposure to carcinogens that are transferred from the mother via the placenta, but little information is available on fetal uptake of such compounds. We analyzed samples of the first urine from newborns whose mothers did or did not smoke cigarettes for the presence of metabolites of the potent tobacco-specific transplacental carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). METHODS: The urine was collected and analyzed for two metabolites of NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronide (NNAL-Gluc). Gas chromatography and nitrosamine-selective detection, with confirmation by mass spectrometry, were used in the analyses, which were performed without knowledge of the origin of the urine samples. RESULTS: NNAL-Gluc was detected in 22 (71%) of 31 urine samples from newborns of mothers who smoked; NNAL was detected in four of these 31 urine samples. Neither compound was detected in the 17 urine samples from newborns of mothers who did not smoke. The arithmetic mean level of NNAL plus NNAL-Gluc in the 27 newborns of smokers for which both analytes were quantified was 0.14 (95% confidence interval [CI] = 0.083-0.200) pmol/mL. The levels of NNAL plus NNAL-Gluc in the urine from these babies were statistically significantly higher than those in the urine from newborns of nonsmoking mothers (geometric means = 0.062 [ 95% CI = 0.035-0.110] and 0.010 [considered as not detected; no confidence interval], respectively; two-sided P <.001). NNAL plus NNAL-Gluc levels in the 18 positive urine samples in which both analytes were quantified ranged from 0.045 to 0.400 pmol/mL, with an arithmetic mean level of 0.20 (95% CI = 0.14-0.26) pmol/mL, about 5%-10% of the levels of these compounds detected in the urine from adult smokers. CONCLUSIONS: Two metabolites of the tobacco-specific transplacental carcinogen NNK can be detected in the urine from newborns of mothers who smoked cigarettes during pregnancy.Keywords
This publication has 37 references indexed in Scilit:
- Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed populationEnvironmental and Molecular Mutagenesis, 1997
- The association of cigarette smoking with placenta previa and abruptio placentaeSeminars in Perinatology, 1996
- CHARACTERIZATION OF 4-AMINOBIPHENYL-HEMOGLOBIN ADDUCTS IN MATERNAL AND FETAL BLOOD SAMPLESJournal of Toxicology and Environmental Health, 1996
- HPLC and GC/MS determination of 4-aminobiphenyl haemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in uteroToxicology, 1996
- Children's Passive and Prenatal Exposure to Cigarette SmokePediatric Annals, 1995
- Comparison of DNA adduct levels in human placenta from polychlorinated biphenyl exposed women and smokers in which CYP 1A1 levels are similarly elevatedTeratogenesis, Carcinogenesis, and Mutagenesis, 1994
- A Review of Smoking in Pregnancy: Effects on Pregnancy Outcomes and Cessation EffortsAnnual Review of Public Health, 1993
- 4-Aminobipheny1 Hemoglobin Adducts in Fetuses Exposed to the Tobacco Smoke Carcinogen In UteroJNCI Journal of the National Cancer Institute, 1991
- Smoking before, during, and after pregnancy.American Journal of Public Health, 1990
- Detection of Smoking-Related Covalent DNA Adducts in Human PlacentaScience, 1986